Jump to content

Topamax Birth Defects


Recommended Posts

Schmidt & Clark, LLP Announces Launch Of Topamax Birth Defects Website

Washington, DC (PRWEB) March 13, 2011

Schmidt & Clark, LLP, a nationally recognized products liability law firm, announced today that it has recently launched a new website regarding the recent U.S. Food & Drug Administration (FDA) birth defect warnings on Topamax (Topiramate).

On March 4, 2011, the FDA issued a warning about the risk of development of cleft lip and/or cleft palate (oral clefts), cranial malformations, genital malformations and other serious birth defects in babies born to women treated with the drug Topamax (topiramate) while pregnant.

The rest at:


Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...